| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4207bffa296c39b1619ebfb1287f98ea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ff81a650b70e913d3b2524b45e4c7320
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d786a81913f3cc8f7704b8b4068f995d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7e004d580e2b73f634395e57a1772b15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e7aa001f3235c07b0298867908d45e21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_69edfdaf14561b54a64abfffb207a2a6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a7b424fac81df3a59a240e10ce25043f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3f221ff601a630ca8afbb9d3a6a30d3e |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1767
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 |
| filingDate |
2012-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2015-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9b951c6924af850a618c926567592a0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2f6914841c0e1d908158f0fa38647f8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e81561028507fc7b56a6f62d1f8d6ca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_558c667d90ba9d0184a2625d955e61a5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3526aa8f04a4e1f91510a52c9d17ec48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bda40201c84684979db9622869e5f3c3 |
| publicationDate |
2015-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-9211313-B2 |
| titleOfInvention |
Methods and compound to inhibit Ca2+ permeable cation conductance |
| abstract |
The present invention provides methods and compositions for inhibiting calcium permeable cation conductance of red blood cells from individuals afflicted with sickle cell anemia. The method comprises exposing the cells to the peptide GsMTx4 and/or variants thereof. |
| priorityDate |
2011-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |